Search Results - "Akahoho, Eugene"
-
1
First-in-Human Phase 1 Trial of Agarose Beads Containing Murine RENCA Cells in Advanced Solid Tumors
Published in Cancer Growth and Metastasis (01-01-2016)“…PURPOSE: Agarose macrobeads containing mouse renal adenocarcinoma cells (RMBs) release factors, suppressing the growth of cancer cells and prolonging survival…”
Get full text
Journal Article -
2
Possible role of the systemic inflammatory reaction in defining tumor responder vs. nonresponder in cancer macrobead therapy
Published in Journal of clinical oncology (01-02-2016)“…Abstract only 572 Background: Peritoneal implantation of mouse renal adenocarcinoma cell-containing (RENCA) Macrobead (MB) represents a cell-system-based…”
Get full text
Journal Article -
3
Abstract CT216: Phase I/IIa non-randomized open-label trials with mouse renal adenocarcinoma (RENCA) cell containing agarose-agarose macrobeads in patients with treatment-resistant metastatic colorectal carcinoma
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Abstract Background: The purpose of phase I/IIa trials of RENCA tumor cells encapsulated in two concentric agarose layers is to evaluate safety and efficacy of…”
Get full text
Journal Article -
4
Abstract 2486: Docetaxel resistant cells display cancer stem cell properties and regulate growth via PI3/Akt signaling
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Both normal organogenesis and tumor development follow a Gompertzian growth curve. An understanding of the mechanisms operating in these apparently…”
Get full text
Journal Article -
5
Phase I/II trial of intraperitoneal implantation of agarose-agarose macrobeads (MB) containing mouse renal adenocarcinoma cells (RENCA) in patients (pts) with advanced colorectal cancer (CRC)
Published in Journal of clinical oncology (20-05-2013)“…Abstract only e14517 Background: RENCA tumor cells encapsulated in two concentric agarose layers which release signals to treat advanced cancers is a novel…”
Get full text
Journal Article -
6
Phase 1 study of intravenous rigosertib (ON 01910.Na), a novel benzyl styryl sulfone structure producing G2/M arrest and apoptosis, in adult patients with advanced cancer
Published in American journal of cancer research (01-01-2013)“…Rigosertib (ON 01910.Na), a synthetic novel benzyl styryl sulfone, was administered to 28 patients with advanced cancer in a Phase I trial in order to…”
Get full text
Journal Article